Skip to main content
NVDA-1.22%AAPL+0.52%GOOGL-2.28%MSFT-0.62%AMZN-0.71%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.68%TSLA-1.98%SKHY+7.05%MU-2.78%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.59%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.40%0005.HK-0.78%HSBA.L-1.76%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.45%AUDJPY-1.72%CHFJPY-1.69%NZDCAD-1.37%NZDUSD-1.36%GBPJPY-1.29%EURJPY-1.28%EURNZD+1.21%GBPNZD+1.17%USDJPY-1.12%CADJPY-1.10%USDZAR+0.93%USDSEK+0.90%USDNOK+0.88%NZDCHF-0.79%AUDNZD+0.76%USDTHB+0.66%AUDCAD-0.65%AUDUSD-0.61%USDPLN+0.60%EURZAR+0.59%USDCHF+0.59%CADCHF+0.58%EURSEK+0.55%EURNOK+0.54%USDMXN+0.53%GBPZAR+0.52%AUDSGD-0.52%AUDDKK-0.47%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.39%CHFSEK+0.36%EURHKD-0.36%CHFNOK+0.35%USDDKK+0.34%NZDSGD-0.34%SGDJPY+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%NOKJPY-0.26%EURPLN+0.26%CHFSGD-0.24%EURCNH-0.23%GBPCAD-0.21%EURCAD-0.19%EURUSD-0.17%GBPUSD-0.17%USDILS+0.16%NZDMXN-0.12%GBPSGD-0.12%USDTRY+0.11%USDCNH+0.09%AUDNOK+0.07%EURSGD-0.05%USDCOP-0.04%AUDCHF-0.03%EURGBP+0.02%PLNJPY+0.02%EURCZK-0.01%USDCAD-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.99%XAGUSD-4.94%GAGUSD-4.91%HG1-4.38%USOIL+3.84%UKOIL+3.77%COFFEE-1.97%GAUUSD-1.74%XAUUSD-1.72%SUGAR+0.87%S1+0.86%C1+0.66%BTCUSD-1.53%ETHUSD-1.38%USDTUSD-0.04%XRPUSD-1.99%SOLUSD-1.56%TRXUSDT+0.15%ZECUSDT-2.42%DOGEUSD-1.93%XMRUSDT-1.84%LINKUSD-0.96%XLMUSD-1.67%BCHUSDT-3.83%LTCUSD-2.04%UNIUSD-2.80%TONUSD+24.88%HBARUSDT-2.07%SUIUSD-2.03%TAOUSDT-2.79%AAVEUSD-2.74%DOTUSDT-2.18%ICPUSDT-1.62%ONDOUSDT-2.73%WLDUSDT-1.47%ATOMUSDT-2.87%ARBUSDT-0.68%JUPUSDT-3.39%INJUSDT-2.47%STXUSDT-3.80%FETUSDT-3.18%TIAUSDT-1.13%PYTHUSDT-1.34%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-3.42%GRTUSDT-3.93%OPUSDT-1.99%POLUSDT-6.32%IOTAUSDT-3.86%AXSUSDT-2.47%FARTCOINUSDT-4.25%EOSUSDT-0.19%DYDXUSDT-0.49%ORDIUSDT-0.44%GALAUSDT-3.93%NOTUSDT-0.68%RONINUSDT-2.64%NVDA-1.22%AAPL+0.52%GOOGL-2.28%MSFT-0.62%AMZN-0.71%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.68%TSLA-1.98%SKHY+7.05%MU-2.78%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.59%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.40%0005.HK-0.78%HSBA.L-1.76%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.45%AUDJPY-1.72%CHFJPY-1.69%NZDCAD-1.37%NZDUSD-1.36%GBPJPY-1.29%EURJPY-1.28%EURNZD+1.21%GBPNZD+1.17%USDJPY-1.12%CADJPY-1.10%USDZAR+0.93%USDSEK+0.90%USDNOK+0.88%NZDCHF-0.79%AUDNZD+0.76%USDTHB+0.66%AUDCAD-0.65%AUDUSD-0.61%USDPLN+0.60%EURZAR+0.59%USDCHF+0.59%CADCHF+0.58%EURSEK+0.55%EURNOK+0.54%USDMXN+0.53%GBPZAR+0.52%AUDSGD-0.52%AUDDKK-0.47%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.39%CHFSEK+0.36%EURHKD-0.36%CHFNOK+0.35%USDDKK+0.34%NZDSGD-0.34%SGDJPY+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%NOKJPY-0.26%EURPLN+0.26%CHFSGD-0.24%EURCNH-0.23%GBPCAD-0.21%EURCAD-0.19%EURUSD-0.17%GBPUSD-0.17%USDILS+0.16%NZDMXN-0.12%GBPSGD-0.12%USDTRY+0.11%USDCNH+0.09%AUDNOK+0.07%EURSGD-0.05%USDCOP-0.04%AUDCHF-0.03%EURGBP+0.02%PLNJPY+0.02%EURCZK-0.01%USDCAD-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.99%XAGUSD-4.94%GAGUSD-4.91%HG1-4.38%USOIL+3.84%UKOIL+3.77%COFFEE-1.97%GAUUSD-1.74%XAUUSD-1.72%SUGAR+0.87%S1+0.86%C1+0.66%BTCUSD-1.53%ETHUSD-1.38%USDTUSD-0.04%XRPUSD-1.99%SOLUSD-1.56%TRXUSDT+0.15%ZECUSDT-2.42%DOGEUSD-1.93%XMRUSDT-1.84%LINKUSD-0.96%XLMUSD-1.67%BCHUSDT-3.83%LTCUSD-2.04%UNIUSD-2.80%TONUSD+24.88%HBARUSDT-2.07%SUIUSD-2.03%TAOUSDT-2.79%AAVEUSD-2.74%DOTUSDT-2.18%ICPUSDT-1.62%ONDOUSDT-2.73%WLDUSDT-1.47%ATOMUSDT-2.87%ARBUSDT-0.68%JUPUSDT-3.39%INJUSDT-2.47%STXUSDT-3.80%FETUSDT-3.18%TIAUSDT-1.13%PYTHUSDT-1.34%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-3.42%GRTUSDT-3.93%OPUSDT-1.99%POLUSDT-6.32%IOTAUSDT-3.86%AXSUSDT-2.47%FARTCOINUSDT-4.25%EOSUSDT-0.19%DYDXUSDT-0.49%ORDIUSDT-0.44%GALAUSDT-3.93%NOTUSDT-0.68%RONINUSDT-2.64%
TG

Taysha Gene Therapies, Inc. (TSHA)

NASDAQ • Healthcare

$5.34
-$0.14 (-2.6%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$5.4
Day Range$5.28 - $5.49
Avg. Volume (3M)2.3M
Market Cap$1.7B
52 Week Range
$2.71$7.3
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$5.4M
Net Income (TTM)
-$149.6M
EPS (TTM)
-$0.42
ROA (TTM)
-31.81%
Current Ratio
17.76

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+27.3%Q1 2026-$0.08
-20.0%Q2 2026-$0.12
-14.8%Q3 2026-$0.13
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc. develops gene therapies for inherited diseases of the central nervous system as a NASDAQ-listed biotechnology company. In qualitative terms it is an early-stage healthcare developer, and its programs use adeno-associated virus, or AAV, vectors to deliver treatments for rare neurological disorders.

Name
Taysha Gene Therapies, Inc.
CEO
Sean Nolan
Website
www.tayshagtx.com
Industry
Healthcare
Year Founded
2019
Employees
99

Today's Snapshot

AI-generated

TSHA closed 2.6% lower at 5.34.

Trading Volume

Below 10d avg (1.9M)

1.8M

vs S&P 500 Today

Underperforming Market

-2.07%

Updated: September 10, 2026 at 12:26 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
TSHA presents a weak technical profile with multiple downward signals: commodity-channel and MACD readings are negative while RSI sits in the mid-30s, indicating subdued momentum. The ADX near 13 signals a lack of a strong trend, yet the stock is trading at or below its 200-day average and short-term moving averages remain bearish, which favors sellers. Volatility is relatively elevated with an ATR around $0.30 and OBV points to distribution. The classic pivot is slightly above the current price, offering nearby resistance. Technical takeaway: Sell — mixed momentum in a low-trend environment with moving-average and volume pressure.
All signals
  • EMA (5 indicators)$5.38 - $5.93
    Sell
  • RSI (14)35.63
    Neutral
  • Stochastic %K (14, 3, 3)9.64
    Buy
  • MACD Level (12, 26)-0.16
    Sell

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$107.04-1.9%
ELVNEnliven Therapeutics, Inc.
$57.45-3.2%
XNCRXencor, Inc.
$24.94-1.5%
ANABAnaptysBio, Inc.
$55.7-1.6%
SANASana Biotechnology, Inc.
$3.17-8.1%
ATAIAtai Beckley Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.